BetaGlue Therapeutics’ Post

The countdown is on: #BIRTO25 is just 2 months away! We're thrilled to announce that Professor Peter Hoskin will join us to discuss "Different scenarios in which reirradiation will be considered, along with radiobiology and treatment techniques in this setting." Book today https://lnkd.in/eZFXGkxV #radiotherapy #oncology

New is coming! Together with RT Team from Państwowy Instytut Medyczny MSWiA we had clinical site visit in Catalan Institute of Oncology to expand and exchange knowledge of #radiosurgery. We are seeing a trend of using high doses #radiation in intracranial and extracranial cases, with Brainlab we support this message by providing technology and deep knowledge. #radiotherapy #oncology

Short lead times and a variety of validated models means a fast and cost-effective platform for your irradiation research. ✅ Tumor targeted radiation to specific sites ✅ Whole body irradiation – myeloablation/sublethal radiation ✅ Combination treatment approaches Chat with a scientist today: https://lnkd.in/d7rKdUxQ #Oncology #Irradiation

Starting your journey with MR-only workflows? Download the white paper from Tampere University Hospital to discover how Gold Anchor can enable MR-only workflows for prostate SBRT. #radiotherapy #prostatecancer #radonc #radiationtherapy #radiationoncology #sabr #stereotactic #oncology #medicalphysics #medicalphysicist #MRI #sbrt #Hypofractionation #goldanchormarker

Published #liquidbiopsy research returns to growth. NCBI/Pubmed data indicate "liquid biopsy" has returned to modest growth in 2024 after two relatively flat years in 2022 and 2023. 2025 is currently on track to return liquid biopsy publications to the kind of double digit growth seen prior to COVID. #oncology #diagnostics #AACR25

The Response Assessment in Neuro-Oncology (RANO) group provides various central nervous system-related tumor response criteria and guidance for assessments. In our on-demand webinar MERIT experts discuss the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for #clinicaltrials. Watch now: https://lnkd.in/g79kJpq9 #oncology #medicalimaging #clinicalresearch #MERITCROwebinar #webinar #MERITCRO #YourClinicalEndpointExpert #oncologyresearch #oncologytrials

🔥 In-Depth Insight from ESMO 2024! Prof Dr Anne Rogiers explains how a combination of neurocognitive and adaptive physiotherapy can improve the cognitive function and quality of life of melanoma survivors. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #Melanoma #Oncology

Learn how tumour growth rate modelling overcomes the limitations of traditional biomarker imaging methods in our whitepaper. https://ow.ly/ax5e50TT4Wb #medicalimaging #oncology

Learn how tumour growth rate modelling overcomes the limitations of traditional biomarker imaging methods in our whitepaper. https://ow.ly/ax5e50TT4Wb #medicalimaging #oncology

Have you registered for the 3rd edition of Ai in oncology? It will be held next May 8-9, 2025 at Aula Magna, Fondazione IRCCS Istituto Nazionale Tumori MIlano. And remember to submit your abstract. The event will be in-person and online. President of the conference Arsela Prelaj Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Politecnico di Milano Arsela Prelaj#oncology #Ai #artificialintelligence #future